Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-22

Clinical Trial Update: A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264) [Phase 4]

View source ↗

Summary

This Phase 4 study evaluated alendronate sodium plus vitamin D3 (Fosamax Plus) versus calcitriol for osteoporosis in postmenopausal women in China; results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcitriol (calcitriol)
  • Fosamax Plus (alendronate sodium / cholecalciferol)

Snippet

Sponsor: Organon and Co | Conditions: Osteoporosis, Postmenopausal | Phase 4 | Status: COMPLETED | Results posted: 2014-07-22